Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to -$563000.0.

  • CV Sciences' Change in Accured Expenses fell 7217.13% to -$563000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 3507.92%. This contributed to the annual value of -$603000.0 for FY2024, which is 8843.75% down from last year.
  • CV Sciences' Change in Accured Expenses amounted to -$563000.0 in Q3 2025, which was down 7217.13% from $34000.0 recorded in Q2 2025.
  • Over the past 5 years, CV Sciences' Change in Accured Expenses peaked at $1.4 million during Q3 2021, and registered a low of -$598000.0 during Q2 2021.
  • Over the past 5 years, CV Sciences' median Change in Accured Expenses value was -$187000.0 (recorded in 2024), while the average stood at -$84473.7.
  • Per our database at Business Quant, CV Sciences' Change in Accured Expenses surged by 262666.67% in 2021 and then plummeted by 115500.0% in 2023.
  • Quarter analysis of 5 years shows CV Sciences' Change in Accured Expenses stood at $1.2 million in 2021, then plummeted by 101.63% to -$20000.0 in 2022, then plummeted by 1155.0% to -$251000.0 in 2023, then skyrocketed by 86.85% to -$33000.0 in 2024, then tumbled by 1606.06% to -$563000.0 in 2025.
  • Its Change in Accured Expenses stands at -$563000.0 for Q3 2025, versus $34000.0 for Q2 2025 and -$547000.0 for Q1 2025.